Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty

Stopped early

Conditions studied: Osteoarthritis

In brief

Study to collect outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA).

Key facts

Study ID

NCT02962362

Run by

Exactech

People needed

73

Starts

2016-08-01

Expected to finish

2021-11-01

Last updated by the study team

2022-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient requires a primary Optetrak Logic Total Knee Arthroplasty
• Patient is skeletally mature with no obvious mechanical defect
• Patient is mentally capable of completing follow-up visits
• Patient is 18 years of age or greater at time of surgery
• Patient will be available for follow-up out to 2 years
• Patient has consented to participate in the clinical study

You may not qualify if…

• Patient has a mental or physical condition that may invalidate evaluation of the data
• Patient is a prisoner
• Surgery is contraindicated according to the applicable product package insert
• Patient has a local or systemic infection
• Patient has a known sensitivity to one or more of the materials in the knee replacement system to be used
• Patient is pregnant

Where it is running

• Exatech, Inc. — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.